Next Article in Journal
TremelImumab and Durvalumab Combination for the Non-OperatIve Management (NOM) of Microsatellite InstabiliTY (MSI)-High Resectable Gastric or Gastroesophageal Junction Cancer: The Multicentre, Single-Arm, Multi-Cohort, Phase II INFINITY Study
Previous Article in Journal
Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
 
 
Article

Article Versions Notes

Cancers 2021, 13(11), 2840; https://doi.org/10.3390/cancers13112840
Action Date Notes Link
article xml file uploaded 7 June 2021 12:22 CEST Original file -
article xml uploaded. 7 June 2021 12:22 CEST Update -
article pdf uploaded. 7 June 2021 12:22 CEST Version of Record https://www.mdpi.com/2072-6694/13/11/2840/pdf-vor
article supplementary file uploaded. 7 June 2021 12:22 CEST - https://www.mdpi.com/2072-6694/13/11/2840#supplementary
article html file updated 7 June 2021 12:23 CEST Original file -
article xml file uploaded 8 June 2021 11:50 CEST Update -
article xml uploaded. 8 June 2021 11:50 CEST Update https://www.mdpi.com/2072-6694/13/11/2840/xml
article pdf uploaded. 8 June 2021 11:50 CEST Updated version of record https://www.mdpi.com/2072-6694/13/11/2840/pdf
article html file updated 8 June 2021 11:51 CEST Update -
article html file updated 26 July 2022 23:11 CEST Update https://www.mdpi.com/2072-6694/13/11/2840/html
Back to TopTop